Engineered TIMPs show promise in fighting glioblastoma invasion
Unveiling the Future of Brain Cancer Treatment: Engineered TIMPs as Potential Game Changers The fight against glioblastoma multiforme (GBM), one of the most aggressive forms of brain cancer, may be witnessing a breakthrough with the advent of engineered tissue inhibitors of metalloproteinases (TIMPs). A groundbreaking study published in Oncotarget Volume 16 on February 28, 2025, … Read more